D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.47% |
| 2 | Consumer Discretionary | 13.31% |
| 3 | Healthcare | 13.17% |
| 4 | Financials | 7.14% |
| 5 | Industrials | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Nice
NICE
$5.79B
| $3.29M | ﹤0.01% |
26,890
+5,772
| +27% | +$650K |
|
1777
CRA International
CRAI
$1.19B
| $3.29M | ﹤0.01% |
65,143
-157
| -0.2% | -$7.09K |
|
1778
CALL
Nexstar Media Group
NXST
$5.88B
| $3.28M | ﹤0.01% |
30,300
+15,000
| +98% | +$1.38M |
|
1779
CALL
Las Vegas Sands
LVS
$32.3B
| $3.28M | ﹤0.01% |
+53,800
| New | +$3.17M |
|
1780
CALL
Children's Place
PLCE
$54.3M
| $3.28M | ﹤0.01% |
+33,700
| New | +$3.07M |
|
1781
PUT
PNC Financial Services
PNC
$99.2B
| $3.27M | ﹤0.01% |
26,700
+8,200
| +44% | +$1.02M |
|
|
DCH
1782
Dauch Corp
DCH
$1.39B
| $3.27M | ﹤0.01% |
+228,786
| New | +$3.31M |
|
1783
Globant
GLOB
$1.57B
| $3.27M | ﹤0.01% |
45,837
+27,204
| +146% | +$1.83M |
|
1784
Turkcell
TKC
$4.72B
| $3.27M | ﹤0.01% |
610,012
-474,174
| -44% | -$3.02M |
|
|
CKH
1785
DELISTED
Seacor Holdings Inc.
CKH
| $3.26M | ﹤0.01% |
77,056
-33,806
| -30% | -$1.44M |
|
|
BROG
1786
DELISTED
Brooge Energy
BROG
| $3.26M | ﹤0.01% |
325,000
| – | – |
|
1787
Protagonist Therapeutics
PTGX
$8.92B
| $3.24M | ﹤0.01% |
257,728
+238,083
| +1,212% | +$2.1M |
|
1788
Equifax
EFX
$20.7B
| $3.23M | ﹤0.01% |
27,303
-103,736
| -79% | -$11.1M |
|
1789
Booz Allen Hamilton
BAH
$8.22B
| $3.23M | ﹤0.01% |
55,582
-20,930
| -27% | -$1.09M |
|
1790
PUT
Cracker Barrel
CBRL
$1.28B
| $3.23M | ﹤0.01% |
20,000
+5,000
| +33% | +$822K |
|
|
MINI
1791
DELISTED
Mobile Mini Inc
MINI
| $3.23M | ﹤0.01% |
95,000
-17,461
| -16% | -$620K |
|
1792
Teva Pharmaceuticals
TEVA
$41.2B
| $3.22M | ﹤0.01% |
205,577
-440,775
| -68% | -$7.77M |
|
|
DLPH
1793
PUT
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
| $3.21M | ﹤0.01% |
166,400
+13,600
| +9% | +$252K |
|
1794
CALL
Crown Castle
CCI
$33.4B
| $3.2M | ﹤0.01% |
25,000
-121,500
| -83% | -$14.3M |
|
1795
PUT
Core Laboratories
CLB
$477M
| $3.2M | ﹤0.01% |
46,400
+26,800
| +137% | +$1.8M |
|
1796
Energizer
ENR
$1.44B
| $3.19M | ﹤0.01% |
71,056
+12,403
| +21% | +$572K |
|
1797
Kearny Financial
KRNY
$606M
| $3.19M | ﹤0.01% |
247,948
+66,643
| +37% | +$875K |
|
1798
CALL
NetEase
NTES
$84.4B
| $3.19M | ﹤0.01% |
66,000
-1,500
| -2% | -$71.3K |
|
1799
Invesco
IVZ
$13B
| $3.19M | ﹤0.01% |
164,953
+53,161
| +48% | +$994K |
|
1800
WillScot Mobile Mini Holdings
WSC
$4.35B
| $3.18M | ﹤0.01% |
+287,098
| New | +$2.98M |
|
Similar funds
D.E. Shaw & Co's Q1 2019 Portfolio in Review
As of Q1 2019, D.E. Shaw & Co held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
D.E. Shaw & Co withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Lyft worth $159M.
- D.E. Shaw & Co's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- D.E. Shaw & Co added most to Pfizer in Q1 2019, an estimated $436M increase.
- D.E. Shaw & Co's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- D.E. Shaw & Co fully exited Shire pic in Q1 2019, selling an estimated $276M.
- D.E. Shaw & Co's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- D.E. Shaw & Co opened 447 new positions and closed 617 in Q1 2019.
- D.E. Shaw & Co's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.